Bayer AG BAYRY recently announced that the FDA had accepted its supplemental new drug application (sNDA) seeking approval for ...

Kerendia (finerenone) is the first drug in its class to show a benefit ... Bayer is running an open-label study – CONFIRMATION-HF – testing Kerendia with Jardiance in patients hospitalised ...

On the heels of approvals in the US, Europe and Japan, Bayer's Kerendia for ... Analysts think the drug has could reach annual sales of $2 billion or more if its label is extended to reflect ...

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer announced today that data from 13 new analyses from across the KERENDIA® (finerenone) comprehensive clinical trial program will be presented at the American ...

Bayer BAYRY announced that the FDA has granted full approval ... The company is working to expand the labels of its key drugs, Nubeqa and Kerendia, which should boost growth.

Bayer BAYRY announced that the FDA has granted full approval to oncology drug ... The company is working to expand the labels of its key drugs, Nubeqa and Kerendia, which should boost growth.